These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35675027)
1. Outpatient parenteral antibiotic therapy (OPAT) and inpatient treatment strategies for emergency department patients with cellulitis: a cost analysis. Yadav K; Kumar S; Chhabra S; Rosenberg H; Eagles D; Suh KN; Ohle R; Nath A; Thavorn K CJEM; 2022 Aug; 24(5):520-528. PubMed ID: 35675027 [TBL] [Abstract][Full Text] [Related]
2. The impact of an outpatient parenteral antibiotic therapy (OPAT) clinic for adults with cellulitis: an interrupted time series study. Yadav K; Mattice AMS; Yip R; Rosenberg H; Taljaard M; Nemnom MJ; Ohle R; Yan J; Suh KN; Stiell IG; Eagles D Intern Emerg Med; 2021 Oct; 16(7):1935-1944. PubMed ID: 33515424 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis. Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277 [TBL] [Abstract][Full Text] [Related]
4. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study. Sumpter C; Russell CD; Mackintosh C Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291 [TBL] [Abstract][Full Text] [Related]
5. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. Chan M; Ooi CK; Wong J; Zhong L; Lye D BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717 [TBL] [Abstract][Full Text] [Related]
6. How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis. Jones GR; Cumming DV; Honeywell G; Ball R; Sanderson F; Seaton RA; Healy B; Hedderwick S; Gilchrist M; J Antimicrob Chemother; 2015 Apr; 70(4):1236-40. PubMed ID: 25558074 [TBL] [Abstract][Full Text] [Related]
7. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Peterson D; McLeod S; Woolfrey K; McRae A Acad Emerg Med; 2014 May; 21(5):526-31. PubMed ID: 24842503 [TBL] [Abstract][Full Text] [Related]
8. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications. Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155 [TBL] [Abstract][Full Text] [Related]
9. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs. Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822 [TBL] [Abstract][Full Text] [Related]
10. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain. González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957 [TBL] [Abstract][Full Text] [Related]
11. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. Dimitrova M; Gilchrist M; Seaton RA BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251 [TBL] [Abstract][Full Text] [Related]
12. Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis. Ibrahim LF; Huang L; Hopper SM; Dalziel K; Babl FE; Bryant PA Lancet Infect Dis; 2019 Oct; 19(10):1101-1108. PubMed ID: 31420292 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service. Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610 [TBL] [Abstract][Full Text] [Related]
14. Impact of first-line dalbavancin for cellulitis on hospital admissions and costs: A case series. Ben-Sassi K; Sarwar S J Glob Antimicrob Resist; 2024 Sep; 38():306-308. PubMed ID: 38821442 [TBL] [Abstract][Full Text] [Related]
15. Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single-centre audit of cellulitis outcomes. Bowhay TR; Tsang T; Wei JCZ; Edwik W; Fridman A; Hubber J; Jo JY; Mckay N; O'Brien C; Osmond-Wallam J; Smythe J; Crump JA; Arnold B Intern Med J; 2024 Feb; 54(2):320-327. PubMed ID: 37461382 [TBL] [Abstract][Full Text] [Related]
16. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis. Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623 [TBL] [Abstract][Full Text] [Related]
18. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398 [TBL] [Abstract][Full Text] [Related]
19. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States. Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089 [TBL] [Abstract][Full Text] [Related]